Real world data analysis of treatment pattern and prognosis of patients with Limited-Stage Small Cell Lung Cancer (LS-SCLC) in Japa
Not Applicable
Recruiting
- Conditions
- imited-Stage Small Cell Lung Cancer
- Registration Number
- JPRN-jRCT1030230655
- Lead Sponsor
- Kitagawa Hiroshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
1. Patients with LS-SCLC pathologically diagnosed by tissue or cytology between January 2014 and December 2020
2. Patients who provided written informed consent, and deceased or untraceable patients for whom an appropriate opt-out approach was taken at the study site
3. Patient aged 18 years or older at the time of diagnosis of LS-SCLC
Exclusion Criteria
1. Patients participating in clinical trials during the observation period of the study
2. Patients who received surgery or only radiation therapy (including SBRT) as 1L treatment for LS-SCLC, and who received no treatment or only best supportive care (BSC) without active treatment for LS-SCLC
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method